Chongqing Beer Profits increase 99.4% is planning hepatitis B vaccine production

Chongqing Beer (600132) published the 2010 Annual report, net profit of 319 million yuan, an increase of 99.42% per share earnings 0.75 yuan, the year-on-year increase of 102.7% per 10 shares of 3 yuan (including tax).　　Chongqing Beer says the holding subsidiary, Jia Chen, is preparing for the production of hepatitis B vaccine.　　Chongqing Beer 2011 Sales of beer 1.012 million liters, operating income of 2.375 billion yuan, year-on-year growth of 1%, 5.08%, 2011 year target to achieve production of 1.154 million liters. Chongqing Beer said, actively promote the treatment of hepatitis B vaccine clinical research work, Jia-Chen is actively engaged in the industrialization of the preparation process research, the pilot workshop is to carry out peptide synthesis, purification, liposome and other related research work, in the exploration, research large-scale production technology and the process of preparing production line process, the training of technical backbone and staff,　　Gradually formed pilot development capacity and industrialization capacity. In the past ten circulating shareholders, heavy warehouse of the largest large number of funds have increased, China Life (601628) personal dividend 005L products in the fourth quarter of last year, 4.77 million shares, column eighth, and last year in the third quarter of Chongqing private Enterprises Hechuan Silver Source Trading Co., Ltd. listed 7th (holding 5.02 million shares), The last quarter has disappeared, due to the end of the quarter of the tenth stock shareholders, 4 million shares, which means that Hechuan Trading Co., Ltd. in the fourth quarter of the reduction of more than 1.02 million shares, the amount of cash in more than more than 60 million yuan. From the total number of shareholders, Chongqing Beer last year at the end of the third quarter of 29897 people, to the end of the dilution to 38409 people.